Morgan Stanley’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.1M Sell
846,478
-182,846
-18% -$1.87M ﹤0.01% 3562
2025
Q4
$10.3M Buy
1,029,324
+220,120
+27% +$2.1M ﹤0.01% 3590
2025
Q3
$7.24M Sell
809,204
-56,794
-7% -$526K ﹤0.01% 3840
2025
Q2
$8.17M Sell
865,998
-191,749
-18% -$1.69M ﹤0.01% 3624
2025
Q1
$11.5M Buy
1,057,747
+113,731
+12% +$1.14M ﹤0.01% 3220
2024
Q4
$8.99M Sell
944,016
-230,813
-20% -$2.34M ﹤0.01% 3496
2024
Q3
$13.2M Buy
1,174,829
+282,342
+32% +$3M ﹤0.01% 3209
2024
Q2
$8.92M Sell
892,487
-89,568
-9% -$910K ﹤0.01% 3403
2024
Q1
$11.3M Sell
982,055
-1,053,849
-52% -$8.95M ﹤0.01% 3250
2023
Q4
$14.8M Buy
2,035,904
+1,207,961
+146% +$9.52M ﹤0.01% 3601
2023
Q3
$7.53M Buy
827,943
+402,706
+95% +$4.83M ﹤0.01% 3381
2023
Q2
$5.18M Sell
425,237
-149,278
-26% -$1.66M ﹤0.01% 3754
2023
Q1
$7.14M Buy
574,515
+162,669
+39% +$2.99M ﹤0.01% 3451
2022
Q4
$7.92M Sell
411,846
-548,509
-57% -$11.6M ﹤0.01% 3302
2022
Q3
$18M Buy
960,355
+307,155
+47% +$6.31M ﹤0.01% 2300
2022
Q2
$11.8M Sell
653,200
-5,322,676
-89% -$86.4M ﹤0.01% 2898
2022
Q1
$95.8M Buy
5,975,876
+5,904,504
+8,273% +$106M 0.01% 892
2021
Q4
$1.75M Sell
71,372
-119,074
-63% -$2.8M ﹤0.01% 4679
2021
Q3
$4.44M Sell
190,446
-769,735
-80% -$18.6M ﹤0.01% 3858
2021
Q2
$26.3M Buy
960,181
+926,136
+2,720% +$26.4M ﹤0.01% 1870
2021
Q1
$1.25M Sell
34,045
-31,321
-48% -$1.11M ﹤0.01% 4586
2020
Q4
$2.46M Buy
65,366
+35,830
+121% +$1.11M ﹤0.01% 3978
2020
Q3
$644K Sell
29,536
-16,473
-36% -$346K ﹤0.01% 4501
2020
Q2
$741K Buy
46,009
+20,054
+77% +$335K ﹤0.01% 4381
2020
Q1
$415K Buy
25,955
+19,575
+307% +$277K ﹤0.01% 4485
2019
Q4
$70K Buy
6,380
+6,280
+6,280% +$62.4K ﹤0.01% 5766
2019
Q3
$1K Sell
100
-100
-50% -$1.02K ﹤0.01% 6529
2019
Q2
$2K Hold
200
﹤0.01% 6447
2019
Q1
$2K Hold
200
﹤0.01% 6440
2018
Q4
$2K Sell
200
-800
-80% -$7.84K ﹤0.01% 6405
2018
Q3
$10K Buy
+1,000
New +$9.7K ﹤0.01% 6297

Other funds holding AHCO